Jeremy Jones is responsible for Wellington UniVentures' portfolio of biotechnology research. Jeremy has returned back to the Wellington UniVentures team after almost three years away leading one of Wellington UniVentures' (formerly Viclink's) spinout successes, AuramerBio, as CEO.
An organic chemist by trade, Jeremy has over 15 years’ experience in the biotech industry in a wide range of markets from pharmaceuticals through to research tools and medical diagnostics. He began his science career at GlycoSyn—the discovery, development and manufacturing arm of Callaghan Innovation—as a Process Development Chemist, before honing his commercialisation skills at KiwiNet, an organisation that supports public commercialisation offices by providing access to investment, training tools and networks.
Excited to be working with such a dynamic and experienced team, Jeremy hopes to use his frontline experience of the biotech start-up world to slingshot the next cohort of Wellington UniVentures companies into market.